Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127043012 | 12704301 | 2 | F | 20101208 | 20160825 | 20160831 | 20160902 | EXP | US-ASTRAZENECA-2010BM13281 | ASTRAZENECA | 21538.00 | DY | M | Y | 127.00000 | KG | 20160903 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127043012 | 12704301 | 1 | PS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | 21332 | 15 | UG | INJECTION | TID | |||||||
| 127043012 | 12704301 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | FN0141 | 0 | 2 | MG | /wk | |||||||
| 127043012 | 12704301 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | 45 | MG | BID | |||||||||
| 127043012 | 12704301 | 4 | C | LASIX | FUROSEMIDE | 1 | 0 | 120 | MG | QD | |||||||||
| 127043012 | 12704301 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | TABLET | ||||||||||
| 127043012 | 12704301 | 6 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | DOSE UNIT:45, THREE TIMES A DAY | 0 | ||||||||||
| 127043012 | 12704301 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | DOSE UNIT:80, EVERY DAY | 0 | ||||||||||
| 127043012 | 12704301 | 8 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | DOSE UNIT:90 | 0 | ||||||||||
| 127043012 | 12704301 | 9 | C | XARELTO | RIVAROXABAN | 1 | Unknown | UNK | 0 | ||||||||||
| 127043012 | 12704301 | 10 | C | BLOOD PRESSURE MEDICATION | UNSPECIFIED INGREDIENT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127043012 | 12704301 | 1 | Type 2 diabetes mellitus |
| 127043012 | 12704301 | 2 | Type 2 diabetes mellitus |
| 127043012 | 12704301 | 4 | Cardiac disorder |
| 127043012 | 12704301 | 6 | Diabetes mellitus |
| 127043012 | 12704301 | 7 | Diabetes mellitus |
| 127043012 | 12704301 | 8 | Diabetes mellitus |
| 127043012 | 12704301 | 9 | Anticoagulant therapy |
| 127043012 | 12704301 | 10 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127043012 | 12704301 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127043012 | 12704301 | Atrial fibrillation | |
| 127043012 | 12704301 | Blood pressure increased | |
| 127043012 | 12704301 | Device malfunction | |
| 127043012 | 12704301 | Dysgeusia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127043012 | 12704301 | 1 | 20101208 | 0 | ||
| 127043012 | 12704301 | 2 | 2015 | 0 |